Ozempic's pen delivers semaglutide at 1.34 mg/mL. A compounded vial labeled "5 mg semaglutide" might be reconstituted at 1, 2.5, 5, or 10 mg/mL — pharmacy-dependent. Reusing a pen-dose number on a compounded vial without recalculating is the most common reason ER triage sees acute semaglutide overdose.
| Product | Form | Concentration | Volume for 0.25 mg dose |
|---|---|---|---|
| Ozempic 2 mg pen | Pre-loaded pen, dialed in mg | 1.34 mg/mL | Dial — no math needed |
| Ozempic 4 mg pen | Pre-loaded pen, dialed in mg | 1.34 mg/mL | Dial — no math needed |
| Compounded vial, Pharmacy A | 5 mg + 2 mL BAC | 2.5 mg/mL | 0.10 mL (10 U) |
| Compounded vial, Pharmacy B | 5 mg + 1 mL BAC | 5 mg/mL | 0.05 mL (5 U) |
| Compounded vial, Pharmacy C | 10 mg + 2 mL BAC | 5 mg/mL | 0.05 mL (5 U) |
| Compounded vial, Pharmacy D | 2 mg + 2 mL BAC | 1 mg/mL | 0.25 mL (25 U) |
The same 0.25 mg dose requires anywhere from 5 units to 25 units on a U-100 syringe across compounded sources — a 5× spread. The mistake that hospitalizes people: switching pharmacies without recalculating.
The more dramatic cases: patient transitions from a compounded vial to a "stronger" compounded vial without knowing it. A 10× error from missing a decimal is rare but documented.
Legitimate compounding pharmacies state the concentration in clear, large print on the vial — typically mg/mL on the front label, not just total mg. They include a dosing chart for common targets. They don't change concentration between refills without explicit notification. Pharmacies that fail any of these checks are the ones whose product ends up in ER triage.
See also the post on FDA's 2026 decision on compounded GLP-1 for the regulatory backdrop.
It should be on the label. If only total mg is listed and not a concentration, the pharmacy expects you to reconstitute it — and you need to know how much diluent to add to hit your intended concentration. Don't guess.
Yes, and they often do. The concentration is a pharmacy-formulation choice, not a property of semaglutide. Two compounded sources at "the same dose" can require very different volumes on the syringe.
Concentration variability is by-design — the pharmacy mixes to spec. Quality issues are different (purity, identity, contamination) and tested via the COA. Both matter; concentration is the more common cause of acute overdose.
Don't use it until you've called the pharmacy and confirmed the concentration in writing. Unlabeled concentration is a near-categorical disqualifier — both for safety and for evidence of a legitimate operation.
Peptide Protocol stores each vial's concentration and warns you when the unit count for the same mg dose changes — the most common overdose signal.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.